MBRX vs MPC · $8.2M cap vs P/E 16, rev $86.19B
Moleculin Biotech Inc (MBRX) versus Marathon Petroleum Corp (MPC) — a side-by-side from cached financials, not a winner call.
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
Latest reported MBRX revenue for 2026-06-30 was $0. Net income was -$20.5M. MBRX currently screens at market cap $8.2M.
Latest reported MPC revenue for 2026-06-30 was $86.19B. Net income was $5.65B. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
MBRX currently screens at market cap $8.2M. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Not investment advice. Open the MBRX and MPC stock pages for the full models.
Not investment advice.